Profile

Robert J. Stratta, M.D.Wake Forest School of Medicine

Doctor Rating

No Rating Available
Why No Ratings?

Robert J. Stratta, M.D.

Professor, Surgical Sciences-Transplant



Clinical Interests

Dialysis Access, Kidney Transplantation, Pancreas Transplantation, Transplant Immunology, Organ Preservation and Procurement, Transplant Immunosuppression, General Surgery, Transplant Surgery

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-0548
Department: 336-716-0548

Email: rstratta@wakehealth.edu

Insurance Accepted »

Media Medical Expert »

Education & Training

  • B.S., University of Notre Dame, 1976
  • M.D., University of Chicago, 1980
  • Internship, University of Utah, 1981
  • Residency, University of Utah College of, 1986
  • Fellowship, University of Wisconsin-Madiso, 1988

Board Certifications

  • American Board of Surgery, Surgery

NPI Number

  • 1346226966
Robert J. Stratta, M.D.

Doctor Rating

No Rating Available
Why No Ratings?

Robert J. Stratta, M.D.

Professor, Surgical Sciences-Transplant
Center on Diabetes, Obesity, and Metabolism
Institute for Regenerative Medicine
Urology

Research Interests

drugs/therapeutic agents pharm, infectious diseases, rehabilitation, transplantation

Contact Information

Department: 336-716-0548

Email: rstratta@wakehealth.edu

Media Medical Expert »

Recent Publications

Rogers J, Katari R, Gifford S, Tamburrini R, Edgar L, Voigt MR, Murphy SV, Igel D, Mancone S, Callese T, Colucci N, Mirzazadeh M, Peloso A, Zambon JP, Farney AC, Stratta RJ, Orlando G. Kidney transplantation, bioengineering and regeneration: an originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair. Expert Rev Clin Immunol. 2016;12(2):169-182.

Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Bowden DW, Hicks PJ, Palmer ND,. APOL1 genotype and kidney transplantation outcomes from deceased African American donors. Transplantation. 2016;100(1):194-202.

Carrier A, Kahn MA, El-Hennawy H, Farney A, Rogers J, Orlando G, Stratta R. Is prolonged cold ischemia a contraindication to using kidneys from acute kidney injury donors? [abstract]. Am J Transplant. 2016;16(Suppl 1):43.

Jones K, Khan A, El-Hennawy H, Farney A, Rogers J, Orlando G, Stratta R. Eversion endarterectomy of the deceased donor renal artery to prevent kidney discard [abstract]. Am J Transplant. 2016;16(Suppl 1):44.

Khan M, El-Hennawy H, Farney A, Rogers J, Orlando G, Brim E, Hairston G, Mangus M, Stratta R. Differential effect of delayed graft function on kidney transplant outcomes [abstract]. Am J Transplant. 2016;16(Suppl 1):53.

Khan M, El-Hennawy H, Rogers J, Farney A, Orlando G, Palanisamy A, Reeves-Daniel A, Stratta R. Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. Am J Transplant. 2016;16(Suppl 1):54.

Stratta RJ, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Palanisamy A, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, El-Hennawy H, Khan M, Rogers J. Dual kidney transplants from adult marginal donors successfully expand the limited deceased donor organ pool. Clin Transplant. 2016;30(4):380-392.

Al-Shraideh Y, Farooq U, El-Hennawy H, Farney AC, Palanisamy A, Rogers J, Orlando G, Khan M, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, Stratta RJ. Single vs dual (en bloc) kidney transplants from donors less than or equal to 5 years of age: a single center experience. World J Transplant. 2016;6(1):239-248.

Stratta RJ, Fridell JA, Gruessner AC, Odorico JS, Gruessner RW. Pancreas transplantation: a decade of decline. Curr Opin Organ Transplant. 2016;21(4):386-392.

Stratta RJ, Gruessner AC, Odorico JS, Fridell JA, Gruessner RW. Pancreas transplantation: an alarming crisis in confidence. Am J Transplant. 2016;():.

Al-Geizawi SM, Singh RP, Zuckerman JM, Requarth JA, Farney AC, Rogers J, Taussig J, Orlando G, Stratta RJ. Role of allograft nephrectomy following kidney graft failure: preliminary experience with pre-operative angiographic kidney embolization. J Nephrol. 2015;28(3):379-385.

Farney AC, Rogers J, Orlando G, Stratta RJ. Simultaneous transplantation of the living donor kidney and deceased donor pancreas and other transplant options for diabetic and uremic patients. Curr Opin Organ Transplant. 2015;20(1):103-107.

El Hennawy H, Rogers J, Farney A, Orlando G, Kahn M, Reeves-Daniel A, Palanisamy A, Stratta R. Does prolonged cold ischemia influence outcomes following pancreas transplantation? [abstract]. Am J Transplant. 2015;15(Suppl 1):112.

El Hennawy H, Farney A, Orlando G, Rogers J, Khan M, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Mangus M, Stratta R. Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. Am J Transplant. 2015;15(Suppl 1):75.

Peloso A, Katari R, Murphy SV, Zambon JP, DeFrancesco A, Farney AC, Rogers J, Stratta RJ, Manzia TM, Orlando G. Prospect for kidney bioengineering: shortcomings of the status quo. Expert Opin Biol Ther. 2015;15(4):547-558.

Peloso A, Katari R, Urbani L, Maghsoudlou P, Fallas MEA, Citro A, Delario G, Willis C, Farney A, Rogers J, Stratta R, Peimonti L, Soker S, Orlando G. Discarded human pancreas as source of ECM scaffold for a new generation bio-artificial endocrine pancreas [abstract]. Am J Transplant. 2015;15(Suppl 1):49.

Stratta RJ, Rogers J, Farney AC, Orlando G, El-Hennawy H, Gautreaux MD, Reeves-Daniel A, Palanisamy A, Iskandar SS, Bodner JK. Pancreas transplantation in C-peptide positive patients: does 'type' of diabetes really matter?. J Am Coll Cardiol. 2015;220(4):716-727.

Freedman BI, Julian BA, Pastan SO, Israni AK, Schladt D, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Hicks PJ, Palmer ND, Adams PL,. Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. Am J Transplant. 2015;15(6):1615-1622.

Salvatori M, Peloso A, Katari R, Soker S, Lerut JP, Stratta RJ, Orlando G. Semi-xenotransplantation: the regenerative medicine-based approach to immunosuppression-free transplantation and to meet the organ demand. Xenotransplantation. 2015;22(1):1-6.

Stratta RJ. The search for the optimal antibody induction strategy in kidney transplantation: still 'hazy' after all these years [commentary]. Clin Transplant. 2015;29(7):569-572.

Ma J, Divers J, Palmer ND, Julian BA, Israni AK, Schladt D, Pastan SO, Chattrabhuti K, Gautreaux MD, Hauptfeld V, Bray RA, Kirk AD, Brown WM, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Guan M, Palanisamy A, Reeves-Daniel AM, Bowden DW,. Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation. Kidney Int. 2015;88(3):584-592.

Palanisamy A, Persad P, Koty PP, Douglas LL, Stratta RJ, Rogers J, Reeves-Daniel AM, Orlando G, Farney AC, Beaty MW, Pettenati MJ, Iskandar SS, Grier DD, Kaczmorski SA, Doares WH, Gautreaux MD, Freedman BI, Powell BL. Donor-derived myeloid sarcoma in two kidney transplant recipients from a single donor. Case Rep Nephrol. 2015;2015():821346.

Peloso A, Petrosyan A, Da Sacco S, Booth C, Zambon JP, O'Brien T, Aardema C, Robertson J, De Filippo RE, Soker S, Stratta RJ, Perin L, Orlando G. Renal extracellular matrix scaffolds from discarded kidneys maintain glomerular morphometry and vascular resilience and retains critical growth factors. Transplantation. 2015;99(9):1807-1816.

Orlando G, Pelso A, Petrosyan A, Da Sacco S, Cravedi P, Zambon J, Soker S, DeFilippo RE, Stratta R, Perin L. Renal ECM scaffolds from discarded kidneys are bioactive, pro-tolerogenic, cyto-compatible and feature an intact, patent and resilient vascular feature an intact, patent and resilient vasculature [abstract]. Tissue Eng Part A. 2015;21(Suppl 1):S103-S104.

Peloso A, Orlando G, Urbani L, Cravedi P, Sordi V, Guoguang N, Citro A, Mcquilling J, Farney A, Iskandar S, Rogers J, Stratta R, Opara E, Piemonti L, Soker S, De Coppi P, Petrosyan A. The human pancreas as a source of pro-tolerogenic extracellular matrix scaffold for a new generation bio-artificial endocrine pancreas [abstract]. Tissue Eng Part A. 2015;21(Suppl 1):S141.

Carrico R, Fridell J, Odorico J, Stratta R, Tyler K, Niederhaus S, Kandaswamy R, Fisher J, Olaitan O, Mujtaba M. Can post-transplant C-peptide be used as an indicator of pancreas graft failure? [abstract]. Xenotransplantation. 2015;22(Suppl 1):S2-S3.

Peloso A, Urbani L, Cravedi P, Katari R, Maghsoudlou P, Fallas ME, Sordi V, Citro A, Purroy C, Niu G, McQuilling JP, Sittadjody S, Farney AC, Iskandar SS, Zambon JP, Rogers J, Stratta RJ, Opara EC, Piemonti L, Furdui CM, Soker S, De Coppi P, Orlando G. The human pancreas as a source of protolerogenic extracellular matrix scaffold for a new-generation bioartificial endocrine pancreas. Ann Surg. 2015;():.

Carrico R, Fridell J, Odorico J, Stratta R, Tyler K, Niederhaus S, Kandaswamy R, Fisher J, Olaitan O, Mujtaba M. Can post-transplant C-peptide be used as an indicator of pancreas graft failure? [abstract]. Transplantation. 2015;99(11 Suppl 2):S3.

Orlando G, Peloso A, Petrosyan A, Da Sacco S, Cravedi P, Zambon JP, O'Brien T, Aardema C, Robertson J, De Filippo RE, Soker S, Stratta RJ, Laura P. Renal ECM scaffolds from discarded kidneys are bioactive, pro-tolerogenic, cyto-compatible and feature an intact, patient and resilient vascular feature an intact, patent and resilient vasculature [abstract]. Transpl Int. 2015;28(Suppl 4):15-16.

Orlando G, Peloso A, Urbani L, Cravedi P, Katari R, Maghsoudlou P, Fallas EMA, Sordi V, Purroy C, Niu GG, Mcquilling JP, Sivanandane S, Farney AC, Iskandar SS, Rogers J, Stratta RJ, Opara EC, Piemonti L, Soker S, De Coppi P. The human pancreas as a source of protolerogenic extracellular matrix scaffold for a new generation bioartificial endocrine pancreas [abstract]. Transpl Int. 2015;28(Suppl 4):129.

Reeves-Daniel A, Palanisamy A, Orlando G, Rogers J, Russell G, Farney A, Burkart J, Stratta R, Freedman B. Analysis of patient refusals for transplantation [abstract]. Am J Transplant. 2015;15(Suppl 3):1761.

Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, El-Hennawy H, Khan M, Gautreaux M, Iskandar S, Stratta R. Import pancreas transplants: good from far or far from good? [abstract]. Am J Transplant. 2015;15(Suppl 3):1068.

Rogers J, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Stratta RJ. Pancreas transplantation with portal venous drainage with an emphasis on technical aspects. Clin Transplant. 2014;28(1):16-26.

Al-Shraideh Y, Farney A, Rogers J, Orlando G, Farooq U, Stratta R. Single versus dual (en bloc) kidney transplants from donors less than 5 years of age: a single center experience [abstract]. Am J Transplant. 2014;14(Suppl 2):72.

Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R. Is recipient BMI greater than or equal to 40 a contraindication to kidney transplantation? [abstract]. Am J Transplant. 2014;14(Suppl 2):74-75.

Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R. Effect of donor obesity on outcomes in expanded criteria donor kidney transplantation [abstract]. Am J Transplant. 2014;14(Suppl 2):74.

Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R. Does high recipient BMI influence outcomes in deceased donor kidney transplantation? A paired donor kidney analysis [abstract]. Am J Transplant. 2014;14(Suppl 2):74.

Stratta RJ, Farney AC, Rogers J, Orlando G. Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective. Expert Rev Clin Immunol. 2014;10(1):117-132.

Al-Shraideh Y, Farney A, Rogers J, Orlando G, Farooq U, Stratta R. Influence of prolonged cold ischemia in the era of marginal donor utilization [abstract]. Am J Transplant. 2014;14(Suppl 2):72.

Fadeyi EA, Stratta RJ, Farney AC, Pomper GJ. Successful unintentional ABO-incompatible renal transplantation: blood group A1B donor into an A2B recipient. Am J Clin Pathol. 2014;141(5):724-726.

Orlando G, Soker S, Stratta RJ, Atala A. Will regenerative medicine replace transplantation? In: Turka LA, Wood KJ, eds. Transplantation. New York: Cold Spring Harbor Laboratory Press;2014: 407-420.

Katari R, Peloso A, Zambon JP, Soker S, Stratta RJ, Atala A, Orlando G. Renal bioengineering with scaffolds generated from human kidneys. Nephron Exp Nephrol. 2014;126(2):119.

Orlando G, Gianello P, Salvatori M, Stratta RJ, Soker S, Ricordi C, Dominguez-Bendala J. Cell replacement strategies aimed at reconstitution of the beta-cell compartment in type 1 diabetes. Diabetes. 2014;63(5):1433-1444.

Al-Shraideh Y, Stratta R, Farney A, Orlando G, Palanisamy A, Reeves-Daniel A, Bodner J, Uloko V, Winfrey S, Kaczmorski S, Doares W, Mangus M, Gautreaux M, Iskandar S, Rogers J. Primary non function after deceased donor kidney transplantation: risks and consequences [abstract]. Transplantation. 2014;98(Suppl 1):631.

Bodner J, Farney A, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Stratta R. Single center analysis of outcomes in 202 consecutive pancreas transplants according to different measures of success [abstract]. Transplantation. 2014;98(Suppl 1):855.

Bodner J, Farney A, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Stratta R. Pancreas transplantation in C-peptide positive patients: does type of diabetes really matter? [abstract]. Transplantation. 2014;98(Suppl 1):864.

Farney A, Rogers J, Doares W, Iskandar S, Orlando G, Adams P, Gautreaux M, Kaczmorski S, Stratta R. 7 year results of a prospective randomized study of alemtuzumab vs rabbit anti-thymocyte globulin induction in kidney and kidney pancreas transplantation [abstract]. Transplantation. 2014;98(Suppl 1):90.

Orlando G, Sedrakyan S, Peloso A, Wang Z, Farney A, Delario G, Rogers J, Stratta R, Soker S, Perin L. ECM scaffolds from discarded human kidneys perform as bio-system when seeded with multipotent progenitor cells [abstract]. Transplantation. 2014;98(Suppl 1):304.

Peloso A, Katari R, Booth C, Wang Z, Zambon J, Farney A, Rogers J, Delario G, Stratta R, Soker S, Orlando G. ECM scaffolds from discarded human kidneys retain growth factors along with intact microstructural morphologies of the innate vasculature [abstract]. Transplantation. 2014;98(Suppl 1):304.

Rogers J, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Bodner J, Stratta R. Pancreas transplantation in African American compared to non African American patients: does recipient ethnicity influence outcomes? [abstract]. Transplantation. 2014;98(Suppl 1):864.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Surgical Sciences-Transplant

Clinical Interests

Dialysis Access, Kidney Transplantation, Pancreas Transplantation, Transplant Immunology, Organ Preservation and Procurement, Transplant Immunosuppression, General Surgery, Transplant Surgery
Robert J. Stratta, M.D.

Robert J. Stratta, M.D.

Professor, Surgical Sciences-Transplant
Center on Diabetes, Obesity, and Metabolism
Institute for Regenerative Medicine
Urology

CP concern for questions/worries
5.0
CP efforts to include in decisions
5.0
CP explanations of prob/condition
5.0
CP spoke using clear language
5.0
Friendliness/courtesy of CP
5.0
Likelihood of recommending CP
5.0
Patients' confidence in CP
5.0
Time CP spent with patient
4.9
Wait time at clinic
4.3



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

4/28/2016

*Dr. Stratta is an excellent care provider. He's passionate about what he does and it shows. I feel very fortunate to have him as my doctor.

4/28/2016

*Dr. Stratta is a very personable, caring professional.

3/9/2016

Everything was explained and even showed to me what I needed to do and how to do it.

2/16/2016

1st meeting of *Dr. Stratta. Was very impressed.

1/26/2016

Knowledgeable & caring, *Dr. Stratta is one of the best doctors I have ever had.

10/27/2015

We can't say enough how great *Dr. Stratta & his staff are. We are very fortunate to have him as a doctor.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.